Adagene (ADAG) Non-Current Assets (2019 - 2025)

Adagene's (ADAG) quarterly Non-Current Assets came in at -$77375.1 billion in Q4 2025, up 11.85% year-on-year from -$69176.7 billion in Q4 2024, and down 6708557021.59% on a QoQ basis from $1.2 million in Q2 2025.

Adagene (ADAG) Non-Current Assets (2019 - 2025) Analysis & Trends

Adagene (ADAG) has 7 years of Non-Current Assets data on file, last reported at -$77375.1 billion in Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 11.85% year-over-year to -$77375.1 billion in Q4 2025; TTM through Dec 2025 was -$165153.0 billion, a 50.54% increase from a year earlier, with the FY2025 full-year figure at -$77375.1 billion, up 11.85% from the prior year.
  • Non-Current Assets for Q4 2025 stood at -$77375.1 billion, down from $1.2 million in the prior quarter.
  • Over the last five years, Non-Current Assets for ADAG reached as high as $3.6 million in Q4 2021 and fell as low as -$175012.9 billion in Q2 2022.
  • Historically, Non-Current Assets has averaged -$73560.3 billion across 5 years, with a median of -$82576.5 billion in 2024.
  • Across the five-year window, Non-Current Assets tumbled 6596974610.4% in 2022 and surged 100.0% in 2024, its largest moves.
  • Year by year, Non-Current Assets stood at $3.6 million in 2021, then sank by 4197914475.81% to -$149315.3 billion in 2022, then rose by 24.02% to -$113443.6 billion in 2023, then rose by 22.62% to -$87777.9 billion in 2024, then rose by 11.85% to -$77375.1 billion in 2025.
  • Per Business Quant data, the three most recent Non-Current Assets figures were -$77375.1 billion in Q4 2025, $1.2 million in Q2 2025, and -$87777.9 billion in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Adagene 198.85 Mn 198.85 Mn - -77,375.09 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 -77,375.09 Bn
Jun 30, 2025 1.15 Mn
Dec 31, 2024 -87,777.92 Bn
Jun 30, 2024 1.98 Mn
Dec 31, 2023 -113,443.61 Bn
Jun 30, 2023 -132,678.62 Bn
Dec 31, 2022 -149,315.28 Bn
Jun 30, 2022 -175,012.85 Bn
Dec 31, 2021 3.56 Mn
Jun 30, 2021 2.65 Mn
Dec 31, 2020 5.17 Mn
Dec 31, 2019 1.97 Mn